Matches in Wikidata for { <http://www.wikidata.org/entity/Q88976571> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q88976571 description "article scientifique publié en 2018" @default.
- Q88976571 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q88976571 description "im Juni 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88976571 description "scientific article published on 01 June 2018" @default.
- Q88976571 description "wetenschappelijk artikel" @default.
- Q88976571 description "наукова стаття, опублікована в червні 2018" @default.
- Q88976571 name "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 name "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 type Item @default.
- Q88976571 label "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 label "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 prefLabel "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 prefLabel "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 P1433 Q88976571-99E4EA43-5965-4A84-A8EC-1FD7A9EC02A9 @default.
- Q88976571 P1476 Q88976571-35F5269F-8523-4A76-AFC7-5A1057CF6386 @default.
- Q88976571 P2093 Q88976571-27A83B08-9183-4FE5-8E20-1720CCEFED37 @default.
- Q88976571 P2093 Q88976571-4013405A-9A37-4541-B086-54857DB91E3E @default.
- Q88976571 P2093 Q88976571-410E59CC-C6B6-4EE0-9773-9BAE1C655D8C @default.
- Q88976571 P2093 Q88976571-46190074-AA7E-43F2-B654-E2C6DE2A98A1 @default.
- Q88976571 P2093 Q88976571-55F77E9A-B708-4496-B38E-7F9C557DAFB4 @default.
- Q88976571 P2093 Q88976571-7012C620-5B2A-4876-AE4B-CB24D8E1B807 @default.
- Q88976571 P2093 Q88976571-9057B612-3903-4264-9F36-B207E8D51DBD @default.
- Q88976571 P2093 Q88976571-CCE01370-EFD6-4684-919E-354A96CF43E5 @default.
- Q88976571 P2093 Q88976571-EC9F861A-F835-4B3E-81FB-BB35EE2279B5 @default.
- Q88976571 P2093 Q88976571-F9892755-B9F7-41F9-A7D5-0617B76C3CD2 @default.
- Q88976571 P304 Q88976571-4D6CECD5-C437-43BE-A17C-2A341946473E @default.
- Q88976571 P31 Q88976571-788A0BC1-29C8-401F-837E-1B91FB4868D7 @default.
- Q88976571 P356 Q88976571-86EB5283-C8B1-4058-9263-777D5EF7068A @default.
- Q88976571 P433 Q88976571-C9A6A880-D005-4A67-88EF-58C199E31AFF @default.
- Q88976571 P478 Q88976571-1846996F-F380-4137-96CF-F801C58682EB @default.
- Q88976571 P50 Q88976571-1D0063D2-D374-4157-A933-B40A08A3FD58 @default.
- Q88976571 P577 Q88976571-E33376CF-833B-43C6-A431-3284671E7526 @default.
- Q88976571 P698 Q88976571-DE7DAC25-7F7E-4BEC-BBCF-776B12AE00BC @default.
- Q88976571 P921 Q88976571-CE8E8D13-C19F-407D-A86B-D8C811B647F7 @default.
- Q88976571 P356 J.JAAD.2018.05.044 @default.
- Q88976571 P698 29864467 @default.
- Q88976571 P1433 Q15757046 @default.
- Q88976571 P1476 "Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)" @default.
- Q88976571 P2093 "David C Wilson" @default.
- Q88976571 P2093 "Esther Estes" @default.
- Q88976571 P2093 "Joel Schlessinger" @default.
- Q88976571 P2093 "Leslie S Baumann" @default.
- Q88976571 P2093 "Mark Bradshaw" @default.
- Q88976571 P2093 "Mary P Lupo" @default.
- Q88976571 P2093 "Stacy R Smith" @default.
- Q88976571 P2093 "Steven E Kempers" @default.
- Q88976571 P2093 "Stuart D Shanler" @default.
- Q88976571 P2093 "Zoe D Draelos" @default.
- Q88976571 P304 "869-877" @default.
- Q88976571 P31 Q13442814 @default.
- Q88976571 P356 "10.1016/J.JAAD.2018.05.044" @default.
- Q88976571 P433 "5" @default.
- Q88976571 P478 "79" @default.
- Q88976571 P50 Q57038615 @default.
- Q88976571 P577 "2018-06-01T00:00:00Z" @default.
- Q88976571 P698 "29864467" @default.
- Q88976571 P921 Q269829 @default.